Comparative Pharmacovigilance Analysis of Approved and Repurposed Antivirals for COVID-19: Insights from EudraVigilance Data

Comparative Pharmacovigilance Analysis of Approved and Repurposed Antivirals for COVID-19: Insights from EudraVigilance Data

<b>Background/Objectives</b>: During the COVID-19 pandemic, several antivirals were approved or repurposed, but their safety profiles have not been fully compared. Pharmacovigilance data help clarify how these drugs perform in real-world use. <b>Methods</b>: This study perfor...

Full description

Saved in:
Bibliographic Details
Main Authors: Paul Andrei Negru, Delia Mirela Tit, Andrei Flavius Radu, Gabriela Bungau, Raluca Anca Corb Aron, Ruxandra Cristina Marin
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Biomedicines
Subjects:
COVID-19
antivirals
EudraVigilance
pharmacovigilance
system organ class
individual case safety reports
Online Access:https://www.mdpi.com/2227-9059/13/6/1387
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2227-9059/13/6/1387

Similar Items